Antidepression of Xingpijieyu formula targets gut microbiota derived from depressive disorder.

Yannan LiLixuan YangJunnan LiWei GaoZhonghui ZhaoKaiqiang DongWenzhe DuanBaoan DaiRong-Juan Guo

Published in: CNS neuroscience & therapeutics (2022)

XPJYF treatment targets inflammation, activation, and glycometabolim in astrocyte via gut microbiota modulation, thereby improve animal behaviors, HPA axis dysfunction, and neurotransmitter synthesis in depression rats.

Keyphrases

oxidative stress
depressive symptoms
bipolar disorder
human milk
smoking cessation